cell therapy

cell-and-gene-therapies-in-rare-disorders-outlook

Jun 09, 2023

Cell and Gene Therapies in Rare Disorders: From Rarity to Recovery

gene-therapy-in-rare-disorders-challenges-in-europe

May 12, 2023

Gene Therapy in Rare Disorders: Acceptance in Europe Faces Challenges

cell-and-gene-therapies-for-rare-disorders-treatment

May 08, 2023

Watershed Moment for Cell Therapies and Complicated Journey of Gene Therapies in Japan

cell-and-gene-therapies-for-diabetes-treatment

May 01, 2023

Cell and Gene Therapies for Diabetes Treatment: A Permanent Cure for Patients?

pharma-news

May 21, 2020

CanSino deals with Precision; Atea raises USD 215 M; Applied Molecular Transport targets for USD 100 M IPO; Cell therapy repairs multiple sclerosis in mice

CAR-T cell therapy market for Non-Hodgkin lymphoma

Apr 17, 2020

CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities

merck

Mar 21, 2019

The Business Cocktail

Oct 23, 2017

Metachromatic Leukodystrophy (MLD): A Rare Indication with great unmet medical need

Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper
Toll-like Receptors Agonist
TLR 7 and 8 Agonist
Gene Therapies Whitepaper

Newsletter/Whitepaper